Molina Healthcare Inc

MOH

Equity

ISIN null / Valor 1538184

New York Stock Exchange, Inc (2026-09-04)

USD 200.80-1.04%

Molina Healthcare Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Molina Healthcare Inc is a prominent health care provider that specializes in offering high-quality, affordable health care services primarily to individuals and families who are beneficiaries of government-sponsored health care programs. Founded in 1980 with a single clinic in Long Beach, the company has significantly expanded its operations over the past four decades. It now operates 19 health plans across the United States, catering to the needs of over 5.1 million members. Molina Healthcare is dedicated to addressing the comprehensive health needs of its members, including their physical, social, and emotional well-being, through a community-based approach tailored to each individual's requirements. The company's growth is also marked by its initiative, the MolinaCares Accord, launched in 2020, which aims to enhance access to health care for its members by making substantial investments in the communities it serves.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

17.5%1Y

-35.3%3Y

-26.9%5Y

Performance

55.9%1Y

48.2%3Y

41.5%5Y

Volatility

10482 M

Market cap (USD)

258,291

Daily traded volume (Shares)

290.43 / 287.24

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

3.00

Innovation:

4.00

Society:

4.00

Nature:

3.00

Muthu Ramanathan

UK, 05 Nov 2025

Solid US managed care leader trading at low valuation with strong premium growth, but recent regulatory risks and high volatility. No dividend. Good for defensive healthcare exposure with 16% upside to analyst target. Monitor policy/earnings closely.

EQUITIES OF THE SAME SECTOR

Haemonetics Corp